Please see dial-in details for the Novo Nordisk’s R&D investor conference call in connection with ADA.
The presentation will be followed by a Q&A session.

Hosted by Karsten Munk Knudsen, EVP & CFO
Presenting
Martin Holst Lange, EVP of Development
Marcus Schindler, EVP of Research and Early Development

 

28 June 2021

16.00 CEST
15.00 BST
10.00 EDT

The call is expected to last approximately 75 minutes.

Dial-in details:

Denmark:....................... +45 35445577

UK/International:.......... +44 3333000804

USA:………..…..........…….+1 6319131422

Confirmation Code:...... 50002476#

 

Webcast: https://edge.media-server.com/mmc/p/tupe78ex

Company announcement

Investor presentation

Financial workbook

Conference call webcast (05 May 2021, 13:00 CET)

Conference call audio link (05 May 2021, 13:00 CET)

London webcast (06 May 2021, 13:00 CET)

London earnings presentation audio link (06 May 2021, 13:00 CET)

1 July - 5 August  2021 Silent period   
5 August 2021 Q2 2021 financial results release 
18 August 2021 Interim dividend payment for B  shares
25 August 2021 Interim dividend payment for ADRs
1 October - 3 November 2021 Silent period   
3 November 2021 Q3 2021 financial results release
1 January - 2 February 2022 Silent period
2 February 2022 Q4 2021 financial results release

07 June: Approval of Wegovy™ in the US

Presentation (Webcast)

Presentation (pdf)

 

21 May: International Operations call

Presentation (Webcast)

Presentation (pdf)

16 December: Decision to enter phase 3 development in Alzheimer’s disease and GLP-1 R&D strategy update

 

30 November: ESG conference call

9 October: Novo Nordisk raises sales and operating profit outlook for 2020

19 June: R&D investor presentation

Stay informed

Stay informed

Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.

Please fill in the fields below to receive our news

E-mail address

Email is required Invalid email address
reCAPTCHA verification required

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Annual Report

Cover page of the Novo Nordisk Annual Report 2020

Annual Report 2020

Download Annual Report